Osaic Holdings’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,689
| Closed | -$7.69K | – | 7827 |
|
|
2025
Q3 | $7.69K | Hold |
1,689
| – | – | ﹤0.01% | 6521 |
|
|
2025
Q2 | $3.63K | Buy |
1,689
+1,544
| +1,065% | +$4.32K | ﹤0.01% | 6717 |
|
|
2025
Q1 | $634 | Sell |
145
-429
| -75% | -$1.93K | ﹤0.01% | 6941 |
|
|
2024
Q4 | $2.68K | Hold |
574
| – | – | ﹤0.01% | 6489 |
|
|
2024
Q3 | $4.03K | Sell |
574
-8,000
| -93% | -$58.1K | ﹤0.01% | 6306 |
|
|
2024
Q2 | $58.8K | Buy |
8,574
+6,524
| +318% | +$60.7K | ﹤0.01% | 4549 |
|
|
2024
Q1 | $29K | Sell |
2,050
-8,000
| -80% | -$122K | ﹤0.01% | 5124 |
|
|
2023
Q4 | $75.7K | Buy |
10,050
+1,113
| +12% | +$10.2K | ﹤0.01% | 4616 |
|
|
2023
Q3 | $134K | Buy |
8,937
+2,622
| +42% | +$47.1K | ﹤0.01% | 4287 |
|
|
2023
Q2 | $100K | Sell |
6,315
-3,000
| -32% | -$31.5K | ﹤0.01% | 4428 |
|
|
2023
Q1 | $66.8K | Buy |
9,315
+9,000
| +2,857% | +$63.6K | ﹤0.01% | 4761 |
|
|
2022
Q4 | $1.82K | Buy |
315
+115
| +58% | +$872 | ﹤0.01% | 6787 |
|
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 6732 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 6835 |
|
|
2022
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 6695 |
|
|
2021
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 6718 |
|
|
2021
Q3 | $4K | Sell |
200
-40
| -17% | -$1.02K | ﹤0.01% | 6601 |
|
|
2021
Q2 | $8K | Hold |
240
| – | – | ﹤0.01% | 6176 |
|
|
2021
Q1 | $24K | Hold |
240
| – | – | ﹤0.01% | 5355 |
|
|
2020
Q4 | $26K | Hold |
240
| – | – | ﹤0.01% | 4991 |
|
|
2020
Q3 | $25K | Hold |
240
| – | – | ﹤0.01% | 4773 |
|
|
2020
Q2 | $50K | Hold |
240
| – | – | ﹤0.01% | 4175 |
|
|
2020
Q1 | $24K | Buy |
+240
| New | +$28K | ﹤0.01% | 4490 |
|
Osaic Holdings's ADVM Position: Q4 2025 in Review
Osaic Holdings sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 1,689 shares — an estimated $7.69K sold.
Osaic Holdings first reported a position in ADVM in Q1 2020 and held it in 23 quarters. The position peaked at $134K in Q3 2023. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- Osaic Holdings reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 1,689 Adverum Biotechnologies shares in Q4 2025, an estimated $7.69K.
- Osaic Holdings first reported a position in Adverum Biotechnologies in Q1 2020 and held it in 23 quarters.
- Osaic Holdings's Adverum Biotechnologies position peaked at $134K in Q3 2023.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.